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ExPHT was associated with reduced cardiac event-free survival (27±7%
vs. 53±9%, p=0.02). In multivariate Cox proportional hazard model, the inde-
pendent predictors of events were resting E/Ea ratio (p=0.01), aortic peak
velocity (p<0.0001), indexed left atrium area (p=0.005), LV global longitu-
dinal strain (p=0.04) and ExPHT (hazard ratio=1.9, p=0.04). When adding Ex-
induced changes in aortic mean gradient to the multivariate model, ExPHT
remained an independent predictor outcome (p=0.033).
Conclusion: In asymptomatic patients with severe AS, the main determinants
of ExPHT are the severity of AS and the Ex-induced changes in LV filling pres-
sure. ExPHT is associated with 2-fold increased risk of cardiac events.
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The mitral stenosis (MS) is the most common valvular disease in the
Maghreb; young women of procreation age are most concerned.
Percutaneous mitral commissurotomy (PMC) has changed the prognosis of
symptomatic MS of pregnant woman.
We report our experience on eighty-three patients requiring PMC during
the third trimester of pregnancy, between March 1998 and May 2010.
Their mean age was 29±4, 9 years; the presumed age of pregnancy was
27.5±2.9 weeks of gestation. Fifteen were in New York Heart Association
class II; fifty in class III and eighteen in class IV. Twelve patients with atrial
fibrillation. Wilkins score calculated in all patients with an average 7±2.
No fetal deaths were noted after the procedure. 1 case of stroke, transient.
No abortions occurred following the procedure.
We report a maternal death fifteen days after delivery. All patients have
improved after the surgery at least one class of NYHA.
Mitral surface area and hemodynamic parameters improved significantly
after PMC; mean left atrial pressure fell from 30±6.3 to 12.2±7 mmHg, mean
transmitral gradient from 21±7.2 to 6.1±3.2 mmHg and mitral valve area from
0.8±0.15 to 2.15±0.2 cm2.
During pregnancy the PMC is the treatment of choice of MS must be per-
formed by an experienced team because the angle of the trans septal puncture
is subject to changes in pregnant women.
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Objectives: This study analyzed the association between pre-operative rest
echocardiography and the 6-month post-operative left ventricular ejection
fraction (LVEF) in organic mitral regurgitation (MR).
Background: LV end-systolic diameter is the marker of LV function in
patients with organic MR associated to survival and post-operative EF, but
still some patients have nowadays a depressed post-operative LV EF despite
correct diameters.
Methods: 88 patients (62.6±1.4 yo) were prospectively recruited. They all
got a complete echocardiography including the assessment of LV-deforma-
tions before the MR repair and all had an echocardiography at 6-month after-
surgery. Exclusion criteria were: coronary artery disease, other organic val-
vular disease, uncontrolled arrhythmia, hemodynamic instability.
Results: The principal parameters not correlated to post-operative LVEF
(0.5±0.08) are displayed in table I. The univariate analysis concluded that: LV
end-systolic diameter (36±0.7 mm, R=–0.34, p=0.009); Left atrial area
(26.4±1.0 cm²; R=–0.37, p=0.011); LV end-diastolic volume (149.9±5.2 ml;
R=–0.31, p=0.019); LV end-systolic volume (52.3±2.5 ml; R=–0.35,
p=0.003); Mitral annulus diameter (37±0.7 mm; R=–0.25; p=0.01). Using a
multivariate linear regression, the GLS/LV end-systolic volume (–4.6±0.3;
p=0.01) and the left atrial diameter (44.7±0.8 mm; p=0.01) were the best pre-
dictor of post-operative LVEF (R²=0.22).
Conclusions: In organic MR, LV end-systolic diameter is a key parameter
to propose surgery. We demonstrated that global longitudinal strain (GLS, %)
normalized for the end-systolic volume is, with the LA size, an important
determinant of post-operative EF.
Table – Main results
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Background: There is uncertainty and debate regarding whether ischemic
mitral regurgitation (MR) is a secondary epiphenomenon resulting from left
ventricular (LV) dysfunction or confers an independent effect on exercise
capacity and outcomes.
Objective: We tested whether ischemic MR negatively impacts exercise
capacity, cardiovascular morbidity and mortality in patients with coronary
artery disease (CAD) and inferior wall motion abnormality patients, indepen-
dent of LV dysfunction.
Methods: Clinical follow-up over 5 years was obtained in 77 patients (age
64±10 years, LVEF 54±11%) with at least mild ischemic MR from CAD and
evidence of inferior wall motion abnormality, who had exercise stress testing
with perfusion imaging within 24 hours of echocardiography. Patients with
active heart failure, ischemia, intrinsic valve disease, pulmonary and vascular
disease were excluded. Exercise capacity (METs, peak double product) was
tested for relation to MR (vena contracta (VC) and jet area), LV size and func-
tion, and pulmonary pressures. Cox proportional hazards analysis assessed
whether MR predicted cardiovascular events, including hospitalization for
heart failure, acute coronary syndrome, and myocardial infarction, and cardio-
vascular (CV) and total mortality.
Results: By multivariate analysis, independent predictors of functional
capacity (METs and peak double product) were MR vena contracta (VC;
r²=0.62, p<0.0001) and LV end-diastolic volume (EDV; r²=0.78, p=0.03). MR
jet area contributed similarly (r²=0.61, p<0.0001). MR VC >2 mm (moderate
ischemic MR) and age were independent predictors of CV events and death
(HR 6.72 for MR, p=0.04).
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mean±SE
Left atrial volume (ml) 44.7±0.8
LV end-diastolic diameter (mm) 55.9±0.9
LVEF (%) 66.2±0.8
LVOT VTI (cm) 17.3±0.5
Mitral inflow E-wave (cm/s) 91.8±5.9
S’ mitral (lateral) (cm/s) 10.4±0.4
Tricuspid maximal velocity (m/s) 2.8±0.1
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Conclusion: In patients with CAD and inferior wall motion abnormality,
MR impacts negatively on exercise capacity and is associated with increased
cardiovascular morbidity and mortality. This effect appears independent of
degree of LV dysfunction.
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Objective: Filamin-A (FlnA) is the first identified gene (chromosome X)
for non-syndromic mitral valve dystrophy. We aim to assess the overall mitral
valve phenotype by echocardiography in male and female patients from a
large P637Q FlnA mutation family.
Methods: Thirty-six patients over 10 year old (41±16 years, 12 males)
with the P637Q FlnA mutation were matched with 18 control subjects. Six
additional patients under 10 year old were also examined.
Results: In male patients both anterior (AL) and posterior (PL) mitral leaflets
were elongated (AL: 25.1±3.2 vs 21.6±2.8 mm in controls, P=0.03; PL: 17.8±3.9
vs 12.3±0.9 mm, P=0.001), thickened (leaflet tip: 3.7±1.1 vs 1.8±0.4 mm,
P=0.0002) and moderately billowed in the left atrium (AL: –1.1±3.4 vs
+3.2±2.2 mm; PL: –2.6±2.5 vs +4.0±2.7 mm, P<0.0005). Anterior and posterior
chordal lengths did not differ significantly with controls but both anterior (APM)
and posterior (PPM) papillary muscles were positioned closer to the mitral annulus
as assessed by the mitral annulus-PM distance to the LV long axis length ratio
(APM: 27±5 vs 34±4%, P=0.01; PPM: 28±8 vs 34±3%, P=0.03). In female
patients lesions were minored as expected in an X-linked disease. Mitral annulus
enlargement was present only in males. No chordal rupture was seen in any
patient. In male and female patients mitral valve dystrophy is unique associating
also a doming aspect in diastole with a restrictive motion predominant on the pos-
terior leaflet. Finally, mitral valves lesions were also clearly identified in younger
patients (3 to 7 year old) particularly in males.
Conclusions: The phenotype of FlnA-related mitral valve dystrophy asso-
ciates mitral leaflet elongation, thickening and billowing with a moderate dias-
tolic doming aspect or restrictive motion, predominant on the posterior leaflet.
Papillary muscle position is displaced closer to the mitral annulus. Mitral
lesions are minored in females as expected in an X-linked disease.
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Objectives: This study analyzed the association between pre-operative rest
and exercise echocardiography and the 6-month post-operative left ventricular
ejection fraction (LVEF) in organic mitral regurgitation (MR).
Background: LV end-systolic diameter is the marker of LV function in
patients with organic MR associated to survival and post-operative EF, but
still some patients have nowadays a depressed post-operative LV EF despite
correct diameters.
Methods: 88 patients (62.6±1.4 yo) were prospectively recruited. They all
got a sub-maximal (to perform a complete echocardiography at rest and at
110±10/min) exercise stress echocardiography before the MR repair and all
had an echocardiography at 6-month after-surgery. Exclusion criteria were:
coronary artery disease, other organic valvular disease, uncontrolled
arrhythmia, hemodynamic instability.
Results: The principal parameters correlated to post-operative LVEF
(0.5±0.08) are displayed in table I. using a multivariate linear regression, the
global longitudinal strain recorded during the exercise (–20.6±0.5%;
p<0.0001), the GLS/LV end-systolic volume (–4.6±0.3; p=0.04) and the left
atrial diameter (44.7±0.8 mm; p=0.01) were the best predictor of post-opera-
tive LVEF (R²=0.48).
Conclusions: In organic MR, LV end-systolic diameter is a key parameter
to propose surgery. We demonstrated that global longitudinal strain (GLS, %)
recorded during a sub-maximal exercise and this GLS normalized for the end-
systolic volume at rest are, with the LA size, important determinant of post-
operative EF.
Table – Main results
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Mitral valve repair is currently evolving. The “respect but not resect”
strategy becomes the standard technique with implantation of artificial
chordae . Limitation can occur with technical complexity for evaluation of
chordae length. The use of surgical and visual criteria allow extension of
ability to achieve that ending point.
Surgical procedure is standardized. Minimally invasive video is our routine
approach. After assessment of mitral lesions; artificial chordae are inserted in
the papillary muscle as much as needed. Then we insert the prosthetic ring to
determine the mitral annulus. This will be the referring plane for repair. Third,
instead of suturing the free edge of posterior leaflet with chordae and lowering
it toward the papillary muscle we lower it to annulus by a double stitch suture.
That allows us to modulate with direct viewing the posterior leaflet’s height.
This creates a very large coaptation zone which plays a role in long-term
results. A video explain the technique.
Determinants of functional capacity
mean±SE R (Pearson) p-value
LV end-systolic diameter (mm) 36±0.7 –0.34 0.009
Left atrial area (cm2) 26.4±1.0 –0.37 0.011
LV end-diastolic volume (ml) 149.9±5.2 –0.31 0.019
LV end-systolic volume 52.3±2.5 60.35 0.003
Mitral annulus diameter (mm) 37±0.7 –0.25 0.01
